Laska E - Search Results

1

d-Cycloserine augmentation of cognitive remediation in schizophrenia.

Cain CK, McCue M, Bello I, Creedon T, Tang DI, Laska E, Goff DC. Cain CK, et al. Among authors: laska e. Schizophr Res. 2014 Mar;153(1-3):177-83. doi: 10.1016/j.schres.2014.01.016. Epub 2014 Jan 30. Schizophr Res. 2014. PMID: 24485587 Free PMC article. Clinical Trial.

2

Classification of the effectiveness of combination treatments.

Laska EM, Meisner M, Tang DI. Laska EM, et al. Stat Med. 1997 Oct 15;16(19):2211-28. doi: 10.1002/(sici)1097-0258(19971015)16:19<2211::aid-sim657>3.0.co;2-3. Stat Med. 1997. PMID: 9330429

3

The Nathan Kline Institute cultural competency assessment scale: psychometrics and implications for disparity reduction.

Siegel CE, Haugland G, Laska EM, Reid-Rose LM, Tang DI, Wanderling JA, Chambers ED, Case BG. Siegel CE, et al. Among authors: laska em. Adm Policy Ment Health. 2011 Mar;38(2):120-30. doi: 10.1007/s10488-011-0337-0. Adm Policy Ment Health. 2011. PMID: 21331634 Free PMC article.

4

Placebo washout in trials of antipsychotic drugs.

Volavka J, Cooper TB, Laska EM, Meisner M. Volavka J, et al. Among authors: laska em. Schizophr Bull. 1996;22(4):567-76. doi: 10.1093/schbul/22.4.567. Schizophr Bull. 1996. PMID: 8938911 Review.

5

Haloperidol blood levels and clinical effects.

Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou JC, Crowner M, et al. Volavka J, et al. Among authors: laska e. Arch Gen Psychiatry. 1992 May;49(5):354-61. doi: 10.1001/archpsyc.1992.01820050018002. Arch Gen Psychiatry. 1992. PMID: 1586270 Clinical Trial.

6

Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.

Brodie JD, Case BG, Figueroa E, Dewey SL, Robinson JA, Wanderling JA, Laska EM. Brodie JD, et al. Among authors: laska em. Am J Psychiatry. 2009 Nov;166(11):1269-77. doi: 10.1176/appi.ajp.2009.08121811. Epub 2009 Aug 3. Am J Psychiatry. 2009. PMID: 19651710 Clinical Trial.

7

Hippocampal hypometabolism predicts cognitive decline from normal aging.

Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ. Mosconi L, et al. Among authors: laska e. Neurobiol Aging. 2008 May;29(5):676-92. doi: 10.1016/j.neurobiolaging.2006.12.008. Epub 2007 Jan 11. Neurobiol Aging. 2008. PMID: 17222480 Free PMC article.

8

Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.

Bartlett EJ, Wolkin A, Brodie JD, Laska EM, Wolf AP, Sanfilipo M. Bartlett EJ, et al. Among authors: laska em. Psychiatry Res. 1991 Oct;40(2):115-24. doi: 10.1016/0925-4927(91)90003-9. Psychiatry Res. 1991. PMID: 1763142

9

Assessing onset of treatment benefit in depression and anxiety: conceptual considerations.

Laska EM, Mallinckrodt CH, Mundt JC, Leber P, Vaccarino AL, Kalali AH, Greist JH. Laska EM, et al. J Clin Psychiatry. 2009 Aug;70(8):1138-45. doi: 10.4088/JCP.09cs05129. J Clin Psychiatry. 2009. PMID: 19758524

10

Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.

Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP. Wolkin A, et al. Among authors: laska e. Biol Psychiatry. 1994 Sep 1;36(5):317-25. doi: 10.1016/0006-3223(94)90629-7. Biol Psychiatry. 1994. PMID: 7993958 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters